Lexicon Pharmaceuticals, Inc. (LXRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lexicon Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.29x | -1.18x | -1.91x | -3.11x | -6.54x | -6.47x |
| P/B Ratio | 3.88x | 1.62x | 3.63x | 2.70x | 5.05x | 2.42x |
| P/S Ratio | 8.38x | 7.60x | 281.00x | 2277.34x | 1925.73x | 15.80x |
| Profitability | ||||||
| Gross Margin | 99.4% | 98.0% | -4798.0% | -37681.3% | -18371.8% | 92.0% |
| Operating Margin | -98.2% | -634.2% | -14265.0% | -72489.2% | -29224.8% | -199.2% |
| Net Margin | -101.1% | -644.8% | -14710.9% | -73341.0% | -29449.0% | -244.1% |
| EBITDA Margin | -97.0% | -592.9% | -14099.3% | -71966.2% | -29126.8% | -171.3% |
| Liquidity | ||||||
| Current Ratio | 4.88x | 5.44x | 5.60x | 6.08x | 4.02x | 3.37x |
| Quick Ratio | 4.87x | 5.44x | 5.58x | 6.08x | 4.02x | 3.37x |
| Leverage | ||||||
| Debt/Equity | 0.58x | 0.74x | 1.14x | 0.47x | 0.02x | 0.08x |
YoY = year-over-year change. Source: FMP..